SEC Form 4 · accession 0001140361-15-023567
Alaunos Therapeutics, Inc. · TCRT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Period of report
Jun 4, 2015
Accepted (ET)
Jun 8, 2015 · 9:18 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001107421
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Jun 4, 2015 | J | 17,830,305 | — | D | 0 | I | by Intrexon Corporation |
| Common StockF1,F3 | Jun 4, 2015 | J | 3,479,006 | — | A | 3,479,006 | I | by R.J. Kirk DOT |
| Common StockF1,F3 | Jun 4, 2015 | J | 23,349 | — | A | 23,349 | I | by JPK 2008 |
| Common StockF1,F3 | Jun 4, 2015 | J | 23,504 | — | A | 23,504 | I | by MGK 2008 |
| Common StockF1,F3 | Jun 4, 2015 | J | 40,954 | — | A | 40,954 | I | by ZSK 2008 |
| Common StockF1,F3 | Jun 4, 2015 | J | 240 | — | A | 240 | I | by Lotus |
| Common StockF1,F3 | Jun 4, 2015 | J | 53,245 | — | A | 53,245 | I | by Staff 2001 |
| Common StockF1,F3 | Jun 4, 2015 | J | 9,537 | — | A | 9,537 | I | by Sr. Staff |
| Common StockF1,F3 | Jun 4, 2015 | J | 337,333 | — | A | 337,333 | I | by JPK 2009 |
| Common StockF1,F3 | Jun 4, 2015 | J | 358,386 | — | A | 358,386 | I | by MGK 2009 |
| Common StockF1,F3 | Jun 4, 2015 | J | 34,318 | — | A | 34,318 | I | by ZSK 2009 |
| Common StockF1,F3 | Jun 4, 2015 | J | 29,066 | — | A | 29,066 | I | by ADC 2010 |
| Common StockF1,F3 | Jun 4, 2015 | J | 154,181 | — | A | 154,181 | I | by MGK 2011 |
| Common StockF1,F3 | Jun 4, 2015 | J | 138,975 | — | A | 138,975 | I | by JPK 2012 |
| Common StockF1,F3 | Jun 4, 2015 | J | 61,262 | — | A | 61,262 | I | by Kellie L. Banks LTT |
| Common StockF1,F4 | Jun 4, 2015 | J | 1,013,146 | — | A | 2,359,608 | I | by Kapital Joe |
| Common StockF1,F4 | Jun 4, 2015 | J | 889,513 | — | A | 889,513 | I | by Mascara Kaboom |
| Common StockF1,F4 | Jun 4, 2015 | J | 395,791 | — | A | 395,791 | I | by Senior Staff 2008 |
| Common StockF1,F4 | Jun 4, 2015 | J | 222,680 | — | A | 222,680 | I | by Staff 2010 |
| Common StockF1,F4 | Jun 4, 2015 | J | 111,339 | — | A | 111,339 | I | by Incentive 2010 |
| Common StockF1,F4 | Jun 4, 2015 | J | 352,477 | — | A | 352,477 | I | by Senior Staff 2007 |
| Common StockF1,F4 | Jun 4, 2015 | J | 176,238 | — | A | 176,238 | I | by Staff 2007 |
| Common StockF1,F4 | Jun 4, 2015 | J | 58,746 | — | A | 58,746 | I | by Incentive 2007 |
| Common StockF1,F4 | Jun 4, 2015 | J | 173,111 | — | A | 173,111 | I | by Staff 2009 |
| Common StockF1,F4 | Jun 4, 2015 | J | 86,556 | — | A | 86,556 | I | by Incentive 2009 |
| Common Stock | holding | — | — | — | 95,648 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Intrexon Corporation declared a dividend of shares of ZIOPHARM Oncology, Inc. common stock held by it to its holders of record as of June 4, 2015.
- F2Randal J. Kirk, directly and through certain affiliates, has voting and dispositive power over a majority of the outstanding capital stock of Intrexon Corporation. Mr. Kirk may therefore be deemed to have voting and dispositive power over the shares of the issuer owned by Intrexon Corporation. Shares held by Intrexon Corporation may be deemed to be indirectly beneficially owned (as defined under Rule 13d-3 promulgated under the Securities Exchange Act of 1934, as amended) by Mr. Kirk. Mr. Kirk disclaims beneficial ownership of such shares, except to the extent of any pecuniary interest therein.
- F3Randal J. Kirk controls each of Randal J. Kirk Declaration of Trust ("R.J. Kirk DOT"), JPK 2008, LLC ("JPK 2008"), MGK 2008, LLC ("MGK 2008"), ZSK 2008, LLC ("ZSK 2008"), Lotus Capital (2000) Co., Inc. ("Lotus"), Third Security Staff 2001 LLC ("Staff 2001"), Third Security Senior Staff LLC ("Sr. Staff"), JPK 2009, LLC ("JPK 2009"), MGK 2009, LLC ("MGK 2009"), ZSK 2009, LLC ("ZSK 2009"), ADC 2010, LLC ("ADC 2010"), MGK 2011, LLC ("MGK 2011"), JPK 2012, LLC ("JPK 2012") and Kellie L. Banks (2009) Long Term Trust ("Kellie L. Banks LTT"). Shares held by these entities may be deemed to be beneficially owned (as defined under Rule 13d-3 promulgated under the Securities Exchange Act of 1934, as amended) by Mr. Kirk. Mr. Kirk disclaims beneficial ownership of such shares, except to the extent of any pecuniary interest therein.
- F4Randal J. Kirk controls each of Kapital Joe, LLC ("Kapital Joe"), Mascara Kaboom, LLC ("Mascara Kaboom"), Third Security Senior Staff 2008 LLC ("Senior Staff 2008"), Third Security Staff 2010 LLC ("Staff 2010"), Third Security Incentive 2010 LLC ("Incentive 2010"), Third Security Senior Staff 2007 LLC ("Senior Staff 2007"), Third Security Staff 2007 LLC ("Staff 2007"), Third Security Incentive 2007 LLC ("Incentive 2007"), Third Security Staff 2009 LLC ("Staff 2009") and Third Security Incentive 2009 LLC ("Incentive 2009"). Shares held by these entities may be deemed to be beneficially owned (as defined under Rule 13d-3 promulgated under the Securities Exchange Act of 1934, as amended) by Mr. Kirk. Mr. Kirk disclaims beneficial ownership of such shares, except to the extent of any pecuniary interest therein.